These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 3292207)

  • 1. Relapse rate as a major determinant of drug selection in peptic ulcer therapy.
    McLean AJ; Harcourt DM; McNeil JJ
    Drugs; 1988 Apr; 35(4):329-33. PubMed ID: 3292207
    [No Abstract]   [Full Text] [Related]  

  • 2. [Long-term drug therapy of peptic ulcer disease. A current review of the status of various anti-ulcer drugs].
    Rohner HG; Rüther N
    Fortschr Med; 1986 Dec; 104(3):933-6. PubMed ID: 2881868
    [No Abstract]   [Full Text] [Related]  

  • 3. Microbes, peptic ulcer, and relapse rates with different drugs.
    McLean AJ; Harrison PM; Ioannides-Demos LL; Byrne AJ; McCarthy P; Dudley FJ
    Lancet; 1984 Sep; 2(8401):525-6. PubMed ID: 6147588
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of protective drugs in the prevention of ulcer relapse.
    Ota S; Terano A
    J Gastroenterol; 1994 Jul; 29 Suppl 7():139-40. PubMed ID: 7921147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of peptic ulcer. H2 receptor blockers].
    Domschke W
    Verh Dtsch Ges Inn Med; 1988; 94():272-5. PubMed ID: 2905101
    [No Abstract]   [Full Text] [Related]  

  • 6. [Indications and successes of conservative therapy in gastroenterology: peptic ulcer].
    Gugler R
    Z Gastroenterol Verh; 1989 Jul; 24():82-4. PubMed ID: 2474995
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study.
    Tzathas C; Triantafyllou K; Mallas E; Triantafyllou G; Ladas SD
    J Clin Gastroenterol; 2008 Jul; 42(6):744-9. PubMed ID: 18277886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Problems in the traditional pharmacotherapy and prevention of peptic ulcer].
    Ryss ES
    Ter Arkh; 1984; 56(9):106-10. PubMed ID: 6393409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New therapy of peptic ulcer].
    Harada T
    Nihon Naika Gakkai Zasshi; 1995 Mar; 84(3):386-9. PubMed ID: 7751774
    [No Abstract]   [Full Text] [Related]  

  • 10. Medical treatment of peptic ulcer disease.
    Ohning G; Soll A
    Am Fam Physician; 1989 Apr; 39(4):257-70. PubMed ID: 2650509
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drug and non-drug immunocorrection in peptic ulcer].
    Petrov AV; Bychkova NG; Perederiĭ VG; Dogotar' VB; Vysotiuk LA
    Lik Sprava; 1993 Apr; (4):100-2. PubMed ID: 8209427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [What is the current therapeutic role of omeprazole in gastroduodenal ulcer disease?].
    Gisbert JP; Boixeda D; Martín de Argila C
    Rev Esp Enferm Dig; 1997 Feb; 89(2):116-23. PubMed ID: 9115818
    [No Abstract]   [Full Text] [Related]  

  • 13. Colloidal bismuth subcitrate in peptic ulcer disease.
    Tytgat GN
    S Afr Med J; 1986 Jul; 70(1):31-3. PubMed ID: 3523793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current drug therapy of peptic ulcer].
    Ryss ES; Fishzon-Ryss IuI
    Klin Med (Mosk); 1989 Jan; 67(1):49-55. PubMed ID: 2654464
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug therapy and therapeutic tactics in gastroduodenal ulcer].
    Grigor'ev PIa; Isakov VA; Iakovenko EP
    Ter Arkh; 1988; 60(8):118-26. PubMed ID: 2906485
    [No Abstract]   [Full Text] [Related]  

  • 16. [Drug evaluation according to the rapidity of healing relapsing of peptic ulcers].
    Kimura K; Yoshida Y; Kasano T; Kihira K; uzuki T
    Nihon Rinsho; 1988 Jan; 46(1):187-91. PubMed ID: 3373754
    [No Abstract]   [Full Text] [Related]  

  • 17. [Current status of maintenance therapy in ulcer disease].
    Wolff G
    Gastroenterol J; 1990; 49(4):176-7. PubMed ID: 2109981
    [No Abstract]   [Full Text] [Related]  

  • 18. [Long-term drug therapy of ulcer disease. Findings for deciding, indications, duration and surgical alternatives].
    Peitsch W
    Fortschr Med; 1986 Sep; 104(36):681-4. PubMed ID: 2876940
    [No Abstract]   [Full Text] [Related]  

  • 19. Some aspects of the critical evaluation of peptic ulcer therapy in patients.
    Mózsik G; Bertelli A; Deak G; Nagy L; Patty I; Simon L; Tárnok F; Jávor T
    Int J Clin Pharmacol Res; 1985; 5(6):447-55. PubMed ID: 4093220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptic ulcer treatment today--is there a role for maintenance therapy?
    Breslin NP; O'Morain C
    Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):116-21. PubMed ID: 9646190
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.